The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro
Abstract
OBJECTIVE: To demonstrate the roles of p16(INK4a) in the senescence of human chondrocytes and the progression of osteoarthritis (OA). METHODS: Immunohistochemistry and reverse transcriptase polymerase chain reaction (RT-PCR) were performed to examine p16(INK4a) expression in fetal, normal age-matched and OA cartilage, and Western blot was used in primary cultured chondrocytes from different origins. To explore a functional p16(INK4a) knockdown in OA chondrocytes, the primary cultured cells were treated with p16(INK4a)-specific small interfering ribonucleic acids (siRNAs). Expression of p16(INK4a), p14(ARF) and p53 was observed by Western blot and RT-PCR. The phosphorylation status of pRb, senescence-associated beta-galactosidase (SA-beta-gal), cell G1/S transition and cell proliferation were studied by Western blot, histological staining, 3H-thymidine incorporation and cell counts respectively. Expression of the collagen I, collagen II and aggrecan genes was measured by semiquantitative RT-PCR. To establish the response of chondrocytes to cytokines, cells were treated with transforming growth factor-beta1 (TGF-beta1) or interleukin-1alpha (IL-1alpha) and examined for incorporation of 3H-thymidine, 3H-proline and 35S-sulphate respectively. RESULTS: A significant increase of p16(INK4a) was detected in OA chondrocytes compared with normal age-matched and fetal chondrocytes (P<0.01) in vivo and in vitro. Treated with p16(INK4a)-specific siRNAs, OA chondrocytes displayed a significant decrease in p16(INK4a) expression with an increase of phosphorylated pRb, but no alteration of p14(ARF) and p53 expression, followed by decreases of senescent features and increases in the expression of some chondrocyte-specific genes and overall repair capacity. CONCLUSIONS: p16(INK4a) is instrumental in the senescence of human articular chondrocytes or OA. The reduction of p16(INK4a) by RNA interference (RNAi) contributed to the recovery of osteoarthritic chondrocytes, suggesting that p16(INK4a) may be a viable future therapeutic candidate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Articular cartilage of patients with OA shows features of senescence, including increased expression of nitric oxide, pro-inflammatory cytokines, particularly IL-1β [8]; p16 [9]; activated DNA damage response; ROS secretion and SA-β-Gal activity [10].”
From Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy (2019) · cites this paper as [9]
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×
“Importantly, other recent findings suggest that normal human cells respond to certain types of DNA damage [18–20], histone deacetylase inhibitors [21] and oncogenic forms of Ras or Raf [ 22 , 23] by adopting a phenotype that closely resembles replicative senescence.”
BackgroundA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors
Felson, D. T., Lawrence, R. C., Dieppe, P. A., Hirsch, R., Helmick, C. G., Jordan, J. M., Kington, R. S., Lane, N. E., Nevitt, M. C., Zhang, Y., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00016 · Cited by 2,565
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
Olovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Cited by
Sorted by citations
Items 101–108 of 108
Um, S.-H., Seo, Y., Seo, H., Lee, K., Park, S. H., Jeon, J. H., Lim, J. Y., Ok, M.-R., Kim, Y.-C., Kim, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26553791
Philipot, D. (2012) · theses.fr (ABES) · doi:10.70675/9b4773fdz718bz4ff2za6ebz25081c8e24f5
Contribution à l'étude du cycle de la cellule endothéliale cornéenne humaine
Pipparelli, A. (2010) · theses.fr (ABES) · doi:10.70675/75d922eaz27b5z4cc8zb0a0z5995152aa929
Rakic, R. (2017) · doi:10.70675/0683fbfbz3f35z4b91za9e1z5844d6fc8026
Millerand, M. (2020) · theses.fr (ABES) · doi:10.70675/d5e9dae6zd9d7z4a05z8fd2zf0ff4ffab0a6
Musculoskeletal disorders: does cuproptosis hold the key?
Wang, C., Liu, D., Ye, Y., Cui, L., Gong, S., Liu, H., & Xie, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1790043
Schmid-Siegel, M., Nagelreiter, F., Gonskikh, Y., Bosch, A., López-Galisteo, R., Tav, K., Heissenberger, C., Liendl-Xu, L., Tessier, A., Marcato, F., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11241215/v1
Metadata
- Authors
- Zhou, H. W.
- Affiliations
- Peking University (CN)
- Corresponding author
- Zhou, H. W.
- ORCID
- Zhou, H. W.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-27
- Volume
- 43
- Issue
- 5
- Pages
- 555-568
- ISSN
- 0263-7103 (ISSN-L)
- 1460-2172
- OpenAlex
- W2134414575
- Cited by
- 108
- References
- 65
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 11 · 2020: 7 · 2019: 10 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 1 · 2013: 5 · 2012: 4
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British journal of rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondrocytes, p16INK4a, cellular senescence, articular cartilage, siRNA knockdown, RNA interference, retinoblastoma protein phosphorylation, type II collagen, aggrecan, TGF-β1, interleukin-1 alpha, chondrocyte proliferation, cartilage repair, p14ARF, p53, G1/S transition
- MeSH terms
- Aged, Aged, 80 and over, Cartilage, Articular, Cells, Cultured, Gene Expression Regulation, Humans, Middle Aged, Transfection, Tumor Suppressor Protein p53, Cytokines, Cellular Senescence, Disease Progression, Chondrocytes, Cyclin-Dependent Kinase Inhibitor p16, Reverse Transcriptase Polymerase Chain Reaction, Osteoarthritis, Knee, Tumor Suppressor Protein p14ARF, RNA, Small Interfering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
